Skip to contentD
Dare Bioscience, Inc.
D
DAREDare Bioscience, Inc. Q2 2018 · 10-Q
Revenue—
Net Income-$3.58M-$3.58MN/M vs Q2 2017 EPS Diluted-$0.32-$0.32N/M vs Q2 2017 Operating Income-$3,624,796N/M Operating Cash Flowderived-$2,688,657N/M
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Dare Bioscience, Inc. · CIK 1401914 · Engraved from SEC EDGAR
ended Jun 30, 2018 · filed Aug 13, 2018 · 44 d after period end